Nutrigenomics Market Analysis 2032
According to the report, the global nutrigenomics market generated $435.7 million in 2022, and is anticipated to generate $2.1 billion by 2032, rising at a CAGR of 17.2% from 2023 to 2032.
The rising prevalence of chronic diseases, advancements in nutrigenomics testing, and growing awareness of personalized nutrition among people across the globe are the factors expected to drive the growth of the global nutrigenomics market in the forecast period from 2023 to 2032. However, limited awareness and government regulation regarding genetic research or testing may hamper market growth in the coming future. On the contrary, the expansion of direct-to-consumer nutrigenomics services and the integration of nutrigenomics in healthcare systems are expected to offer remunerative opportunities for the expansion of the nutrigenomics market during the forecast period.
Request Sample of the Report on – https://www.alliedmarketresearch.com/request-sample/A129082
Nutrigenomics Statistics:
- The global nutrigenomics market is projected to reach $2.1 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 17.2% from 2023 to 2032.
- In North America, the demand for nutrigenomics is expected to expand rapidly due to growing health disorders.
- The reagents and kits sub-segment is expected to grow at the highest CAGR of 17.5% during the forecast period from 2023 to 2032.
- The obesity sub-segment accounted for the largest market share of 37.0% in 2022 and is expected to the highest grow at a CAGR of 18.1% during the forecast period.
- The hospitals & clinics sub-segment of the global market accounted for the highest share of 46.8% in 2022 and is projected to continue to hold major market share by 2032.
- The nutrigenomics market in the North America region accounted for the largest share of 43.9% in 2022 and is predicted to be dominant and grow at the highest CAGR of 18.0% during the forecast period.
Real-World Applications
- DNA-Based Diet Plans: Companies now offer at-home DNA testing kits that analyze genes related to metabolism, vitamin absorption, lactose intolerance, and more.
- Targeted Supplementation: Know which nutrients you may need more of — like Vitamin D or Omega-3 — based on your body’s ability to process and store them.
- Allergy and Sensitivity Insights: Identify potential food intolerances or sensitivities at the genetic level, even before they cause noticeable symptoms.
- Better Blood Sugar Control: If your genes affect how you respond to carbs, you can adjust your diet to prevent insulin resistance.
Segments Overview
Product Type: Reagents and Kits Sub-segment to Flourish Immensely by 2032
The reagents and kits sub-segment accounted for the largest global nutrigenomics market share of 65.1% in 2022 and is expected to grow at the highest CAGR of 17.5% during the forecast period from 2023 to 2032. This is mainly due to the increase in number of chronic diseases and personalization of diet to prevent diseases due to unhealthy lifestyle and dietary change. Besides, the rising adoption of telehealth services that include pharmacy services, online medical visits, and memberships is driving the demand for reagents & kits.
Applications: Obesity Sub-segment to Dominate During the Forecast Period
The obesity sub-segment accounted for the largest market share of 37.0% in 2022 and is expected to the highest grow at a CAGR of 18.1% during the forecast period. This is mainly due to the increasing overweight population across the globe. The World Obesity Federation’s 2023 Atlas anticipates that more than 4 billion people, constituting 51% of the global population, will be either obese or overweight in the next 12 years.
End User: Hospitals & Clinics Sub-segment to Hold Major Market Share by 2032
The hospitals & clinics sub-segment of the global market accounted for the highest share of 46.8% in 2022 and is projected to continue to hold major market share by 2032. This is mainly owing to the rapidly evolving and uncertain regulatory landscape of telehealth. The presence of medical professionals in hospitals and clinics ensures accurate sample collection, result interpretation, and effective communication of findings to patients. This professional expertise enhances the credibility of nutrigenomic testing.
Region: North America Market to be the Most Dominant During the Forecast Period
The nutrigenomics market in the North America region accounted for the largest share of 43.9% in 2022 and is predicted to be dominant and grow at the highest CAGR of 18.0% during the forecast period. This growth is mainly due to growing health disorders in the region. In addition, companies in North America are releasing genetic reports for their subscribers, which is contributing towards nutrigenomics research. Moreover, the presence of major nutrigenomics companies in the region is expected to generate opportunities in the nutrigenomics testing market in the coming years.
Leading Players in the Nutrigenomics market:
- Nutrigenomix Inc.
- Metagenics, Inc.
- The Gene Box
- DNA Life
- GX Sciences Inc.
- Genova Diagnostics
- Holistic Health
- Cura Integrative Medicine
- Xcode Life
- Interleukin Genetics
Read More:
Global Radiopharmaceuticals Market Booms with Rising Demand for Targeted Diagnostics
Global Tattoo Removal Market Set for Strong Expansion Through 2035 | Registering a CAGR of 19.1%
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
